| MTAP | Methylthioadenosine phosphorylase |
| CDKN2A | Cyclin-dependent kinase inhibitor 2A |
| CDKN2B | Cyclin-dependent kinase inhibitor 2B |
| IHC | Immunohistochemistry |
| CNS | Central nervous system |
| IDH | Isocitrate dehydrogenase |
| WHO | World Health Organization |
| FISH | Fluorescence in situ hybridization |
| NGS | Next-generation sequencing |
| PXA | Pleomorphic xanthoastrocytoma |
| LCNEC | Large cell neuroendocrine carcinoma |
| NSCLC | Non-small cell lung cancer |
| PRMT5 | Protein arginine methyltransferase 5 |
| MTA | Methylthioadenosine |
| MAT2A | Methionine adenosyltransferase 2A |
| Erk1/2 | Extracellular signal-regulated kinases 1 and 2 |
| Akt | Protein kinase B |
| PDAC | Pancreatic ductal adenocarcinoma |
| GIST | Gastrointestinal stromal tumor |
| Ki-67 | Kiel-67 proliferation index |
| NIH | National Institutes of Health |
| RCC | Renal cell carcinoma |
| EMT | Epithelial–mesenchymal transition |
| UC | Urothelial carcinoma |
| HD | Homozygous deletion |